Celebrating 20 Years of IP Excellence

Monoclonal antibodies and Patents – How the Madras High Court interpreted Section 3(c)

Monoclonal antibodies and Patents – How the Madras High Court interpreted Section 3(c)

The Madras High Court clarified the interpretation of Section 3(c) in the context of monoclonal antibodies patent in Genmab A/S v. Assistant Controller of Patents. The court emphasized the importance of novelty and technical advancement for patent eligibility. Continue Reading Monoclonal antibodies and Patents – How the Madras High Court interpreted Section 3(c)

Read more